Tasly U.S. to participate in BioJapan, October 10-14

September 21, 2022

Tasly U.S. to participate in BioJapan, October 10-14

 114 total views,  2 views today

Tasly U.S. will join with 11 other Maryland-based biopharmaceutical-focused organizations as an exhibitor at BioJapan 2022, Asia’s premier partnering event for the global biotechnology industry, in Yokohama, Japan, on October 10-14.  The company will discuss its aims to become a world-renowned innovator in pharmaceuticals, biologics, and nutraceuticals, and focus in particular on Dantonic® (T89), recognized as the first herbal medicine-derived compound to complete an FDA Phase III global clinical trial.

Uncategorized